WS Management’s Cellectis CLLS Stock Holding History

WS Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,907	Closed	-$117K	–	74
2022 Q3	$117K	Hold	50,907	–	–	0.01%	71
2022 Q2	$144K	Hold	50,907	–	–	0.01%	76
2022 Q1	$231K	Hold	50,907	–	–	0.01%	67
2021 Q4	$413K	Hold	50,907	–	–	0.03%	60
2021 Q3	$642K	Hold	50,907	–	–	0.07%	66
2021 Q2	$788K	Hold	50,907	–	–	0.08%	69
2021 Q1	$1.03M	Sell	50,907 -2,599	-5%	-$64.3K	0.11%	59
2020 Q4	$1.45M	Hold	53,506	–	–	0.15%	48
2020 Q3	$990K	Hold	53,506	–	–	0.11%	53
2020 Q2	$952K	Sell	53,506 -9,203	-15%	-$140K	0.12%	48
2020 Q1	$577K	Sell	62,709 -3,152	-5%	-$47K	0.06%	61
2019 Q4	$1.13M	Hold	65,861	–	–	0.1%	49
2019 Q3	$685K	Sell	65,861 -7,263	-10%	-$97.7K	0.05%	61
2019 Q2	$1.14M	Sell	73,124 -8,648	-11%	-$154K	0.07%	61
2019 Q1	$1.5M	Sell	81,772 -11,021	-12%	-$195K	0.09%	58
2018 Q4	$1.54M	Sell	92,793 -60,766	-40%	-$1.41M	0.08%	68
2018 Q3	$4.33M	Hold	153,559	–	–	0.14%	62
2018 Q2	$4.34M	Buy	+153,559	New	+$4.57M	0.12%	62

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WS Management's CLLS Position: Q4 2022 in Review

WS Management sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 50,907 shares — an estimated $117K sold.

WS Management first reported a position in CLLS in Q2 2018 and held it in 18 quarters. The position peaked at $4.34M in Q2 2018. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

WS Management reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
WS Management sold 50,907 Cellectis shares in Q4 2022, an estimated $117K.
WS Management first reported a position in Cellectis in Q2 2018 and held it in 18 quarters.
WS Management's Cellectis position peaked at $4.34M in Q2 2018.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on WS Management's 13F filing for Q4 2022, filed 14 Feb 2023.